All stocks Β· INDSWFTLAB
IL

Ind-Swift Laboratories Ltd.

INDSWFTLAB BSE Drug Manufacturers - Specialty & Generic Healthcare

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offer…

ISIN INE915B01019
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia. It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services. The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.

Key Metrics

as of Sep 2026
Market Cap3,099 Cr
P/E47.60
Div Yield0.00 %
Book Valueβ‚Ή159.00
52w Highβ‚Ή390.00
52w Lowβ‚Ή87.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 186.00 173.00 153.00 150.00 148.00 150.00 122.00 3.00 30.00 517.00 276.00 270.00 299.00
Expenses 153.00 152.00 144.00 148.00 145.00 158.00 122.00 15.00 35.00 430.00 222.00 207.00 239.00
Operating Profit 33.00 20.00 9.00 2.00 3.00 -9.00 -1.00 -12.00 -5.00 87.00 54.00 63.00 60.00
OPM % 18.00 12.00 6.00 1.40 2.10 -6.00 -0.80 -443.00 -15.00 17.00 20.00 23.00 20.00
Other Income 7.00 -3.00 18.00 18.00 15.00 216.00 16.00 13.00 11.00 458.00 7.00 7.00 6.00
Depreciation 8.00 8.00 9.00 7.00 7.00 7.00 6.00 0.00 0.00 20.00 14.00 13.00 14.00
Interest 1.00 -2.00 1.00 2.00 1.00 -27.00 10.00 0.00 0.00 3.00 21.00 21.00 20.00
Profit before tax 32.00 12.00 18.00 11.00 10.00 226.00 -1.00 0.00 6.00 523.00 27.00 36.00 31.00
Tax % 25.00 -27.00 39.00 21.00 17.00 4.00 0.00 0.00 0.00 6.00 19.00 17.00 45.00
Net Profit 24.00 15.00 11.00 9.00 8.00 218.00 -1.00 0.00 6.00 491.00 22.00 30.00 17.00
EPS in Rs 2.81 1.72 1.32 1.07 1.34 35.98 -0.15 0.05 1.05 83.05 3.66 5.09 2.89

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 636.00550.001,673.001,152.00988.00857.00752.00724.00731.00694.00639.00646.00
Expenses 590.00563.001,371.00930.00788.00676.00610.00599.00604.00589.00532.00557.00
Operating Profit 46.00-13.00302.00222.00200.00180.00142.00125.00127.00105.00107.0089.00
OPM % 7.00-2.4018.0019.0020.0021.0019.0017.0017.0015.0017.0014.00
Other Income 36.00304.00476.007.0034.0023.0036.00130.0016.0015.001.00-31.00
Interest 1.003.00104.0092.0096.00100.00107.0092.0028.0088.00106.00117.00
Depreciation 31.0024.0080.0057.00131.0087.0090.00104.0087.0088.0085.0084.00
Profit before tax 50.00264.00594.0079.008.0016.00-20.0059.0029.00-56.00-83.00-143.00
Tax % 15.003.0010.0046.00171.00127.006.0035.0038.00-29.00-29.00-17.00
Net Profit 43.00256.00536.0042.00-6.00-4.00-21.0039.0018.00-40.00-59.00-119.00
EPS in Rs 4.9042.2590.747.19-0.97-0.74-3.528.113.89-8.88-14.37-29.09
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 87.0069.0067.0060.0060.0060.0060.0048.0046.0045.0042.0042.00
Reserves 1,284.001,095.00731.00616.00573.00579.00585.00542.00497.00480.00473.00551.00
Borrowings 20.0037.00214.00854.00944.00996.001,031.001,148.001,083.001,242.001,457.001,413.00
Other Liabilities 263.00221.00396.00259.00226.00182.00184.00174.00371.00353.00238.00233.00
Total Liabilities 1,654.001,422.001,408.001,788.001,803.001,817.001,860.001,913.001,997.002,121.002,210.002,238.00
Fixed Assets 306.00273.00192.00587.00630.00752.00843.00913.00934.001,042.001,095.001,114.00
CWIP 10.000.0051.008.0010.0019.0011.0020.0069.0070.0082.00115.00
Investments 330.00269.00167.0085.00111.0055.0026.0026.0026.0026.0026.0026.00
Other Assets 1,008.00880.00998.001,108.001,052.00991.00979.00953.00968.00982.001,007.00983.00
Total Assets 1,654.001,422.001,408.001,788.001,803.001,817.001,860.001,913.001,997.002,121.002,210.002,238.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity -40.00-39.00-166.00183.00136.00135.00123.00-75.0071.0093.0080.00100.00
Cash from Investing Activity -100.00-110.00-28.00-14.003.00-10.00-10.00-2.00-17.00-31.00-30.00-37.00
Cash from Financing Activity 145.0074.00658.00-168.00-140.00-124.00-133.00100.00-62.00-69.00-48.00-64.00
Net Cash Flow 5.00-75.00464.001.00-1.001.00-20.0023.00-8.00-7.003.000.00
Free Cash Flow -127.00-65.00-229.00170.00123.00131.00112.00-90.0050.0061.0050.0060.00
CFO/OP % -72.00303.00-55.0082.0068.0075.0087.00-60.0056.0088.0075.00112.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 108.00106.0056.00149.00158.00171.00187.00168.00191.00179.00205.00212.00
Inventory Days 184.00137.0028.00253.00303.00304.00330.00302.00305.00317.00377.00319.00
Days Payable 185.00141.00114.00114.00120.00106.00122.00110.00112.0088.00137.00119.00
Cash Conversion Cycle 107.00102.00-30.00287.00342.00368.00395.00359.00384.00409.00445.00412.00
Working Capital Days 120.0083.00-7.00226.00249.00243.00256.00225.00-59.00-106.00-35.0032.00
ROCE % 5.001.0021.0013.007.007.005.004.003.002.002.001.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 42.93 43.00 39.49 39.49 40.94 40.94 42.01 42.01 42.01 42.01 42.01 42.01
FIIs 10.70 13.88 14.33 14.80 4.27 3.07 0.46 0.65 1.27 0.26 0.31 0.17
DIIs 0.17 0.00 0.68 0.68 0.91 0.91 0.94 0.94 0.94 8.03 18.73 19.49
Public 46.19 43.14 45.50 45.02 53.88 55.08 56.61 56.41 55.81 49.72 38.96 38.34
No. of Shareholders 40,881 39,222 42,121 43,780 28,709 28,117 28,752 28,883 25,461 22,439 24,633 25,405

Corporate Actions

20 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 24 Sep 2024 β€” β€” β€” Annual General Meeting
Other 22 Sep 2023 β€” β€” β€” Annual General Meeting
Other 22 Sep 2022 β€” β€” β€” Annual General Meeting
Other 23 Sep 2021 β€” β€” β€” Annual General Meeting
Other 23 Sep 2020 β€” β€” β€” Annual General Meeting
Other 24 Sep 2019 β€” β€” β€” Annual General Meeting
Other 19 Sep 2018 β€” β€” β€” Annual General Meeting
Other 14 Sep 2017 β€” β€” β€” Annual General Meeting
Other 20 Sep 2016 β€” β€” β€” Annual General Meeting
Other 18 Sep 2015 β€” β€” β€” Annual General Meeting
Other 18 Sep 2014 β€” β€” β€” Annual General Meeting
Other 24 Sep 2013 β€” β€” β€” Annual General Meeting
Other 21 Sep 2012 β€” β€” β€” Annual General Meeting
Dividend 20 Sep 2011 β€” β€” 1.00
Dividend 16 Sep 2010 β€” β€” 1.00
Dividend 17 Sep 2009 β€” β€” 1.00
Dividend 18 Sep 2008 β€” β€” 1.00
Dividend 21 Sep 2007 β€” β€” 1.00
Dividend 22 Sep 2006 β€” β€” 1.50
Dividend 22 Sep 2005 β€” β€” 1.50

Announcements

5 filings